-_ _ -_~--_ _~_ _ _ _ _~~ Vitamin B, deficiency was induced in mice by maintenance for 4 weeks on a vitamin B,-free diet. Tryptophan metabolism was assessed by determining the urinary excretion of tryptophan metabolites, the metabolism of It4Cjtryptophan in vivo and the formation of tryptophan and niacin metabolites by isolated hepatocytes. The vitamin B,-deficient animals excreted more xanthurenic acid and 3-hydroxykynurenine, and less of the niacin metabolites N'-methyl nicotinamide and methyl-2-pyridone-4-carboxamide, than did control animals maintained on the same diet supplemented with 5 mg vitamin B,/kg. After intraperitoneal injection of ['4C]tryptophan, vitamin B,-deficient mice showed lower liberation of I4CO, from Imethylene-'4Cjtryptophan and IU-L4C)tryptophan than did controls, indicating impairment of kynureninase (EC 3 . 7 . 1 .3) activity. There was no difference between the two groups of animals in the metabolism of (ring-2-I4C]tryptophan. Hepatocytes isolated from the vitamin B,-deficient animals formed more 3-hydroxykynurenine and xanthurenic acid than did cells from control animals, but also formed more NADP and free niacin. 
Vitamin B, deficiency results in abnormal metabolism of tryptophan because the enzyme kynureninase (EC 3.7.1 .3) in the oxidative pathway of tryptophan metabolism (see Fig.  1 ) is pyridoxal phosphate (vitamin B,)-dependent. In deficiency its activity is severely impaired, so that, especially after a loading dose of tryptophan, there is increased accumulation of its substrates, kynurenine and 3-hydroxykynurenine, and increased formation of xanthurenic and kynurenic acids. This results in increased urinary excretion of these compounds (Lepkovsky & Nielson, 1942; Lepkovsky et al. 1943) . The ability to metabolize a test dose of tryptophan has been used widely as a means of assessing vitamin B, nutritional status (Coursin, 1964; Allegri et a]. 1978) , although the validity and reliability of the tryptophan load test have been challenged (Coon & Nagler, 1969; Bender & Wynick, 1981; Bender, 1983h, 1987 .
In vitro investigation of the kinetic variables of the enzymes involved in the oxidative pathway of tryptophan metabolism suggests that even under normal conditions the activities of kynureninase (Knox, 1953) and kynurenine hydroxylase (EC 1.14.13.9) (Bender & McCreanor, 1985) are so low that they are likely to provide (secondary) ratelimiting steps in the pathway. Significant amounts of kynurenine, 3-hydroxykynurenine, kynurenic acid and xanthurenic acid are excreted by animals fed on a diet providing adequate vitamin B,, suggesting that in vivo the activities of kynurenine hydroxylase and kynureninase may be inadequate to cope with the metabolic flux through tryptophan dioxygenase (EC 1 .13.11. I 1).
Studies of tryptophan metabolism in isolated hepatocytes do not support the view that kynureninase may be a rate-limiting step under normal conditions. Salter e l al. (1986) determined metabolic flux through discrete sectors of the oxidative pathway and calculated that the control coefficient (that proportion of the total control of metabolic flux that can be attributed to an individual step) for kynureninase was < 0.004. The over-whelming control of metabolic flux was attributable to tryptophan dioxygenase (control coefficient 0.75) and the uptake of tryptophan into the cells (control coefficient 0.25). Induction of tryptophan dioxygenase by the previous administration of glucocorticoid hormones (the conditions under which Knox (1953) suggested that kynureninase would become ratelimiting) resulted in an increase in the control coefficient of transport to 0 7 5 and a decrease in the control coefficient of tryptophan dioxygenase to 0.25. The present study was designed to investigate further the metabolism of tryptophan in vitamin B,-deficient animals ; in hepatocytes from vitamin Be-deficient animals, kynureninase does have a significant control coefficient (0.41) (Stanley et af. 1985) .
M E T H O D S
Male BK albino mice were purchased as weanlings from Banting & Kingman (Hull, Humberside) and were assigned randomly to receive either a vitamin B,-free diet or the same diet supplemented with 5 mg pyridoxine hydrochloride/kg, as described previously (Symes et al. 1984) . The animals were maintained in groups of five per cage, and received food and water ad lib.
Once each week the animals were transferred to individual metabolism cages, and urine was collected for 24 h. Each urine sample was diluted to 20 ml with distilled water and then frozen and stored at -20" until required for the determination of tryptophan metabolites, as described later. They were allowed free access to food and water during this period.
After the animals had been receiving the diets for 3-4 weeks, they received 0.1 pCi [14C]tryptophan by intraperitoneal injection at 09.00 hours, and were transferred to separate sealed glass jars, through which air was passed slowly from a compressor. Exhaled air was bubbled through I ml 2-methoxyethylamine in a narrow tube to trap 14C0,. The 2-methoxyethylamine was changed at 10 min intervals for 2 h and was then mixed with 3 ml Ecoscint-A water-miscible scintillation fluid (National Diagnostics, Aylesbury, Bucks) and radioactivity was determined in a liquid-scintillation spectrometer. Each animal received an intraperitoneal injection of [ring-2-14C]tryptophan (CEA, Gif-sur-Yvette, France ; specific activity 50 Ci/mol) to assess metabolic flux through tryptophan dioxygenase and formylkynurenine formamidase (EC 3.5.1 .9) on the first day, [methylene-14C]tryptophan (Amersham International plc, Amersham, Bucks; specific activity 59 Ci/ mol) to assess metabolic flux through kynurenine hydroxylase and kynureninase on the next day, and [U-14C]tryptophan (NEN; Du Pont (UK) Ltd, Stevenage, Herts; specific activity 556 Ci/mol) to assess overall oxidative metabolism on the third day. (In previous studies (Bender, 1983 a) , [benzene ring-U-14C]tryptophan was used to give a more precise estimate of metabolic flux through picolinate carboxylase (EC 4.1 . 1 .45) and the total oxidative branch of the pathway ; this positional isomer of [14C]tryptophan is no longer available.) On the day the animals received [ring-2-14C]tryptophan, they received a second intraperitoneal injection, of 0.1 pCi [14C]formate (Amersham International plc, Amersham, Bucks; specific activity 59 Ci/mol), 2 h after the injection of tryptophan, in order to ensure that any changes in the liberation of 14C0, from [ring-2-14C]tryptophan were not due to changes in the onward metabolism of the formate released by formylkynurenine formamidase. Similarly, after the injection of [methylene-14C]tryptophan the animals received an injection of 0.1 pCi [U-14C]alanine (Amersham International plc, Amersham, Bucks; specific activity 171 Ci/mol), in order to exclude artifacts due to changes in the onward metabolism of the alanine released by kynureninase. In each case the collection of "CO, was continued for a further 2 h.
During the fourth and fifth weeks after weaning, isolated hepatocytes were prepared from one animal each day by perfusion of the liver with collagenase (EC 3.4.24.3) from the superior vena cava to the hepatic portal vein, as described previously (Bender & Olufunwa, 1988) ; the viability of the cells was assessed by Trypan blue exclusion. After the superior vena cava had been cannulated, a sample of blood (0.2-0.5 ml) was drawn from the inferior vena cava, which was then ligated. The hepatic portal vein was then cut, and perfusion commenced.
The hepatocytes were incubated for 30 min at 37" in a final volume of 10 ml (5-10 mg dry weight of cells/incubation) with 60 pmol tryptophan/l. The formation of kynurenine, 3-hydroxykynurenine, xanthurenic acid, total nicotinamide nucleotides (NAD and NADP, oxidized and reduced forms), total niacin (nicotinic acid plus nicotinamide), N'-methyl nicotinamide, and methyI-2-pyridone-4-carboxamide, was determined as described previously (Bender & Olufunwa, 1988) .
2-2
The blood which was withdrawn from the inferior vena cava before the beginning of the perfusion was centrifuged at 2000 g for 15 min. Plasma tryptophan was determined by the norharman fluorimetric method (Denckla & Dewey, 1967) . The activation of aspartate aminotransferase (EC 2.6.1 . I ) by pyridoxal phosphate was determined in the lysed washed erythrocyte pellet as an index of vitamin B, nutritional status, by the modification of the [2,3-"H]aspartate method of Schuster rt al. (1978) described previously (Bender rt ul. 1982) , with and without pre-incubation in 0.25 mmol pyridoxal phosphate/ 1. The results have been expressed as the activation coefficient, the ratio of activity after activation of apo-enzyme with pyridoxal phosphate : basal activity of native holoenzyme.
Urine xanthurenic and kynurenic acids and kynurenine were determined after chromatography of 10 ml samples of the diluted urine on small columns of Dowex 50W (Hi) ion-exchange resin, as described by Satoh & Price (1958) . Xanthurenic and kynurenic acids were determined fluorimetrically (Satoh & Price, 1958) and kynurenine colorimetrically after diazotization and coupling to naphthyl ethylenediamine (Joseph & Risby, 1975) . 3-Hydroxykynurenine was determined fluorimetrically after reaction with ptoluene sulphonyl chloride in acetone (Watanabe er ut. 1970 ), N1-methyl nicotinamide by the small-scale modification of the alkali-ketone fluorimetric method of Carpenter & Kodicek (1950) that has been described previously (Bender, I980) , and methyl-2-pyridone-4-carboxamide colorimetrically by hypobromite-catalysed rearrangement to the amine, diazotization and coupling to naphthyl ethylenediamine (Holman, 1954) , after removal of potentially interfering substances with MB-5 1 13 mixed-bed ion-exchange resin (Bender, 1983 h) .
R E S U L T S
As shown in Table I , the vitamin B,-deficient animals grew more slowly than those fed on the control diet, showing a mean gain in weight of 11 % over the 4 weeks of the experiment, compared with a gain of 31 YO in the control animals. After 4 weeks on the diet, the erythrocyte aspartate aminotransferase activation coefficient was 1.44 (SE 0.103) in the deficient animals, and 1.09 (SE 0.066) in the control animals (0.05 > P > 0.01, t test). There was no significant difference in the plasma concentration of tryptophan (control 72.7 (SE 5.27) ,umol/I, vitamin B,-deficient 76.4 (SE 8.54); P > 0.1, f test). Table 1 shows the urinary excretion of tryptophan metabolites at weekly intervals through the study. 3-Hydroxykynurenine excretion was significantly higher in the deficient animals throughout the experiment. Urinary kynurenic acid showed no consistent difference between the two groups of animals ; xanthurenic acid excretion was slightly higher throughout, significantly so after 3 and 4 weeks on the deficient diet. N1-methyl nicotinamide and methyl pyridone carboxamide excretion were consistently lower in the deficient animals; the differences were significant in weeks 3 and 4 for methyl pyridone carboxamide, and in week 4 for "-methyl nicotinamide. Fig. 2 shows the effects of vitamin B, deficiency for 4 weeks on the metabolism of [''Cltryptophan, formate and alanine in intact mice. There was no significant effect of diet on the liberation of 14C0, from [ring-2-14C]tryptophan or [14C]formate ( P > 0.1, analysis of variance), although there was a suggestion of an early greater rate of tryptophan metabolism in the deficient animals ('"CO., liberation at 10 min: 7.34 (SE 0.724) counts/min per lo3 cpm injected in deficient animals, 4.47 (SE 0.364) in controls; P < 0-001, t test). As shown in Table 2 , there was no significant difference in the total amount of W O , recovered . . 
Values for the deficient group were significantly different from those for the control group As shown in Table 3 , hepatocytes isolated from vitamin B,-deficient animals formed more 3-hydroxykynurenine, xanthurenic acid, NADP and niacin than did cells from animals fed on the control diet. There was no significant difference in the formation of kynurenine, N1-methyl nicotinamide or methyl pyridone carboxamide.
D I S C U S S I O N
Previous studies with rats (Symes et ul. 1984; Bowden et ul. 1986; Bender et ul. 1989) have shown that maintenance for 3 4 weeks from weaning on the vitamin B,-free diet used in the present study results in a significant degree of vitamin B, depletion, as assessed by the liver content of pyridoxal phosphate. In the present study, in mice, the same diet led to the development of significant vitamin B, deficiency, as assessed by the erythrocyte aspartate aminotransferase activation coefficient.
The deficient mice showed the expected abnormalities of excretion of tryptophan metabolites : an elevation of urinary 3-hydroxykynurenine and xanthurenic acid, even in the absence of a loading dose of tryptophan. There was also a reduction in the excretion of N'-methyl nicotinamide and methyl pyridone carboxamide, the two end-products of the pathway. The metabolic fate of aminocarboxymuconic semialdehyde (see Fig. 1 ) will depend on the balance between the (saturable) enzymic reaction of picolinate carboxylase (leading to total oxidation) and non-enzymic cyclization to quinolinic acid (the precursor of NAD), which has linear kinetics. Hence, the formation of NADP changes considerably as the rate of formation of aminocarboxymuconic semialdehyde changes. This in turn depends on the rate of metabolic flux through the pathway from tryptophan (Mehler et ul. 1964; Tkeda et ui. 1965) . Reduced activity of kynureninase resulting from vitamin B, deficiency would, therefore, be expected to result in the reduced formation of NADP and the niacin metabolites W-methyl nicotinamide and methyl pyridone carboxamide shown in Table 1 .
The production of "CO, from [14C]tryptophan in intact animals, shown in Fig. 2 and Table 2 , is also in agreement with expectations. There was no effect of vitamin B, deficiency on the production of "CO, from [ring-2-l4C]tryptophan, which reflects the activity of tryptophan dioxygenase. There was clear impairment of the activity of kynureninase in vivo in vitamin B, deficiency, with a significant reduction in the peak height and total production of ' T O , from [methylene-14C]tryptophan in the deficient animals. This was not an artifact of reduced metabolism of the alanine released by kynureninase : indeed there was a slight increase in the production of ' T O , from [U-14C]alanine in the deficient animals. The production of "CO, from [U-14C]tryptophan showed the same effect as did that from [methylene-14C]tryptophan, suggesting that the activity of picolinate carboxylase, and hence total oxidation of tryptophan via acetate, is not affected by vitamin B, deficiency.
The results with isolated hepatocytes are at variance with those in intact animals. As shown in Table 3 , there was indeed increased formation of 3-hydroxykynurenine and xanthurenic acid in hepatocytes from vitamin B,-deficient animals, but this was accompanied by increased formation of NADP and free niacin, whereas urinary excretion of niacin metabolites was reduced in the deficient animals.
It is difficult to reconcile the results in intact animals, which show the expected increase in urinary excretion of kynurenine metabolites and reduced excretion of niacin metabolites in vitamin B, deficiency, with those obtained in hepatocytes isolated from the same animals, which show increased formation of both kynurenine and niacin metabolites. It is possible that vitamin B, deficiency affects either the catabolism of NADP or the methylation of nicotinamide to N'-methyl nicotinamide, although there is no evidence that the enzymes involved are vitamin B,-dependent. It may be that an artifact is induced during the isolation of hepatocytes by perfusion of the liver with collagenase, so that the isolated hepatocyte is not a useful model for such studies. Alternatively, it is possible that studies of whole-body tryptophan metabolism reflect not only hepatic, but also extra-hepatic, metabolism of tryptophan and kynurenine.
